Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice
Open Access
- 1 July 2011
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 121 (7), 2845-2854
- https://doi.org/10.1172/jci57324
Abstract
In addition to its role as an essential neurotransmitter, dopamine serves important physiologic functions in organs such as the kidney. Although the kidney synthesizes dopamine through the actions of aromatic amino acid decarboxylase (AADC) in the proximal tubule, previous studies have not discriminated between the roles of extrarenal and intrarenal dopamine in the overall regulation of renal function. To address this issue, we generated mice with selective deletion of AADC in the kidney proximal tubules (referred to herein as ptAadc–/– mice), which led to selective decreases in kidney and urinary dopamine. The ptAadc–/– mice exhibited increased expression of nephron sodium transporters, decreased natriuresis and diuresis in response to l-dihydroxyphenylalanine, and decreased medullary COX-2 expression and urinary prostaglandin E2 excretion and developed salt-sensitive hypertension. They had increased renin expression and altered renal Ang II receptor (AT) expression, with increased AT1b and decreased AT2 and Mas expression, associated with increased renal injury in response to Ang II. They also exhibited a substantially shorter life span compared with that of wild-type mice. These results demonstrate the importance of the intrarenal dopaminergic system in salt and water homeostasis and blood pressure control. Decreasing intrarenal dopamine subjects the kidney to unbuffered responses to Ang II and results in the development of hypertension and a dramatic decrease in longevity.This publication has 46 references indexed in Scilit:
- Dopamine ReceptorsHypertension, 2011
- New insights into angiotensin receptor actions: from blood pressure to agingCurrent Opinion in Nephrology and Hypertension, 2011
- Intrarenal Dopamine Attenuates Deoxycorticosterone Acetate/High Salt–Induced Blood Pressure Elevation in Part Through Activation of a Medullary Cyclooxygenase 2 PathwayHypertension, 2009
- Disruption of the Ang II type 1 receptor promotes longevity in miceJCI Insight, 2009
- Intrarenal Dopaminergic System Regulates Renin ExpressionHypertension, 2009
- Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cellsJCI Insight, 2008
- Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidneyProceedings of the National Academy of Sciences of the United States of America, 2006
- Mechanisms of Disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivityNature Clinical Practice Nephrology, 2006
- Renal cortical cyclooxygenase 2 expression is differentially regulated by angiotensin II AT 1 and AT 2 receptorsProceedings of the National Academy of Sciences of the United States of America, 2006
- The Role of Renal Dopaminergic Activity in the Pathophysiology of Essential Hypertension.Japanese Heart Journal, 1996